rs16910744

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4BP6_Very_StrongBP7BA1

The NM_000507.4(FBP1):​c.276G>T​(p.Thr92Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00944 in 1,614,140 control chromosomes in the GnomAD database, including 1,070 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T92T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.046 ( 551 hom., cov: 32)
Exomes 𝑓: 0.0056 ( 519 hom. )

Consequence

FBP1
NM_000507.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.141

Publications

6 publications found
Variant links:
Genes affected
FBP1 (HGNC:3606): (fructose-bisphosphatase 1) Fructose-1,6-bisphosphatase 1, a gluconeogenesis regulatory enzyme, catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate. Fructose-1,6-diphosphatase deficiency is associated with hypoglycemia and metabolic acidosis. [provided by RefSeq, Jul 2008]
FBP1 Gene-Disease associations (from GenCC):
  • fructose-1,6-bisphosphatase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.18).
BP6
Variant 9-94620386-C-A is Benign according to our data. Variant chr9-94620386-C-A is described in ClinVar as Benign. ClinVar VariationId is 137364.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.141 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.156 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FBP1NM_000507.4 linkc.276G>T p.Thr92Thr synonymous_variant Exon 2 of 7 ENST00000375326.9 NP_000498.2 P09467
FBP1NM_001127628.2 linkc.276G>T p.Thr92Thr synonymous_variant Exon 3 of 8 NP_001121100.1 P09467Q2TU34
FBP1XM_006717005.5 linkc.30G>T p.Thr10Thr synonymous_variant Exon 2 of 7 XP_006717068.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FBP1ENST00000375326.9 linkc.276G>T p.Thr92Thr synonymous_variant Exon 2 of 7 1 NM_000507.4 ENSP00000364475.5 P09467

Frequencies

GnomAD3 genomes
AF:
0.0463
AC:
7039
AN:
152144
Hom.:
544
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.159
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0199
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00118
Gnomad OTH
AF:
0.0315
GnomAD2 exomes
AF:
0.0132
AC:
3330
AN:
251484
AF XY:
0.00981
show subpopulations
Gnomad AFR exome
AF:
0.165
Gnomad AMR exome
AF:
0.0109
Gnomad ASJ exome
AF:
0.00565
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00134
Gnomad OTH exome
AF:
0.00879
GnomAD4 exome
AF:
0.00559
AC:
8166
AN:
1461878
Hom.:
519
Cov.:
32
AF XY:
0.00491
AC XY:
3571
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.165
AC:
5509
AN:
33474
American (AMR)
AF:
0.0114
AC:
508
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00478
AC:
125
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000406
AC:
35
AN:
86256
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53420
Middle Eastern (MID)
AF:
0.0137
AC:
79
AN:
5768
European-Non Finnish (NFE)
AF:
0.00104
AC:
1157
AN:
1112006
Other (OTH)
AF:
0.0124
AC:
751
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
443
886
1329
1772
2215
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
192
384
576
768
960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0465
AC:
7077
AN:
152262
Hom.:
551
Cov.:
32
AF XY:
0.0439
AC XY:
3268
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.159
AC:
6599
AN:
41510
American (AMR)
AF:
0.0199
AC:
305
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00519
AC:
18
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00116
AC:
79
AN:
68026
Other (OTH)
AF:
0.0312
AC:
66
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
307
614
920
1227
1534
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0217
Hom.:
153
Bravo
AF:
0.0532
Asia WGS
AF:
0.0100
AC:
36
AN:
3478
EpiCase
AF:
0.00142
EpiControl
AF:
0.00142

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 27, 2012
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Fructose-biphosphatase deficiency Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.18
CADD
Benign
5.4
DANN
Benign
0.65
PhyloP100
-0.14
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16910744; hg19: chr9-97382668; API